Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127615001 | 12761500 | 1 | I | 2012 | 20160913 | 20160920 | 20160920 | PER | US-ASTRAZENECA-2016SE97555 | ASTRAZENECA | 61.00 | YR | M | Y | 86.20000 | KG | 20160920 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127615001 | 12761500 | 1 | PS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 21366 | 5 | MG | TABLET | TIW | |||||||
| 127615001 | 12761500 | 2 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 21366 | 2 | DF | TABLET | QD | |||||||
| 127615001 | 12761500 | 3 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 21366 | 2.5 | MG | TABLET | QD | |||||||
| 127615001 | 12761500 | 4 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 0 | |||||||||||
| 127615001 | 12761500 | 5 | C | PRAVASTATIN. | PRAVASTATIN | 1 | Oral | 0 | |||||||||||
| 127615001 | 12761500 | 6 | C | TAMSULOSIN | TAMSULOSIN | 1 | Oral | 0 | .4 | MG | QD | ||||||||
| 127615001 | 12761500 | 7 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 81 | MG | QD | ||||||||
| 127615001 | 12761500 | 8 | C | LORAZEPAM. | LORAZEPAM | 1 | Oral | 0 | .2 | MG | QD | ||||||||
| 127615001 | 12761500 | 9 | C | ADVIL | IBUPROFEN | 1 | 0 | ||||||||||||
| 127615001 | 12761500 | 10 | C | ALEVE | NAPROXEN SODIUM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127615001 | 12761500 | 1 | Low density lipoprotein decreased |
| 127615001 | 12761500 | 2 | Low density lipoprotein decreased |
| 127615001 | 12761500 | 3 | Low density lipoprotein decreased |
| 127615001 | 12761500 | 6 | Micturition urgency |
| 127615001 | 12761500 | 7 | Haemodilution |
| 127615001 | 12761500 | 8 | Anxiety |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127615001 | 12761500 | Anxiety | |
| 127615001 | 12761500 | Back pain | |
| 127615001 | 12761500 | Musculoskeletal pain | |
| 127615001 | 12761500 | Prostatic specific antigen abnormal |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127615001 | 12761500 | 4 | 2009 | 0 | ||
| 127615001 | 12761500 | 6 | 2013 | 0 | ||
| 127615001 | 12761500 | 7 | 2009 | 0 | ||
| 127615001 | 12761500 | 8 | 2016 | 0 |